Saeed Sadigh-Eteghad1, Mahnaz Talebi, Mehdi Farhoudi. 1. Department of Molecular Neurobiology, Neurosciences Research Center, Tabriz University of Medical Sciences, Iran. saeed.sadigetegad@gmail.com
Abstract
OBJECTIVE: To obtain a better insight into the effect of the epsilon (e) 4 allele of the apolipoprotein E gene (APOE) on the risk of late onset Alzheimer`s disease (LOAD), and assess its heterogeneity in geographic regions. METHODS: We performed a systemic review and meta-analysis of available studies. An electronic and manual search of international and local databases was conducted to identify relevant studies between January 1991 and December 2011 in the Central Library of Tabriz University of Medical Sciences, Tabriz, Iran. All articles related to patients with LOAD that evaluated APOE genotype were included in our study. Two reviewers assessed the inclusion/exclusion criteria, summarized, and analyzed the extracted data. We assessed 21 separate studies overall involving 1480 subjects; the total sample size was 6777. RESULTS: According to the results, there was no heterogeneity among the included studies. The total APOE e4 allele frequency was significantly higher in AD cases compared with control subjects (35% versus 11.43%, p<0.001). The odds ratio (OR) for APOE e4 frequency in AD and control groups was 3.98 (95% confidence interval [CI]: 3.44-4.61). This factor in various geographic regions was different. CONCLUSION: This meta-analysis is strongly supportive of the hypothesis that the APOE e4 allele increases the risk of sporadic LOAD, and determination of the e4 allele in populations may be a useful tool for monitoring demented patients and planning healthcare policies.
OBJECTIVE: To obtain a better insight into the effect of the epsilon (e) 4 allele of the apolipoprotein E gene (APOE) on the risk of late onset Alzheimer`s disease (LOAD), and assess its heterogeneity in geographic regions. METHODS: We performed a systemic review and meta-analysis of available studies. An electronic and manual search of international and local databases was conducted to identify relevant studies between January 1991 and December 2011 in the Central Library of Tabriz University of Medical Sciences, Tabriz, Iran. All articles related to patients with LOAD that evaluated APOE genotype were included in our study. Two reviewers assessed the inclusion/exclusion criteria, summarized, and analyzed the extracted data. We assessed 21 separate studies overall involving 1480 subjects; the total sample size was 6777. RESULTS: According to the results, there was no heterogeneity among the included studies. The total APOE e4 allele frequency was significantly higher in AD cases compared with control subjects (35% versus 11.43%, p<0.001). The odds ratio (OR) for APOE e4 frequency in AD and control groups was 3.98 (95% confidence interval [CI]: 3.44-4.61). This factor in various geographic regions was different. CONCLUSION: This meta-analysis is strongly supportive of the hypothesis that the APOE e4 allele increases the risk of sporadic LOAD, and determination of the e4 allele in populations may be a useful tool for monitoring demented patients and planning healthcare policies.
Authors: Sarah K Madsen; Greg Ver Steeg; Adam Mezher; Neda Jahanshad; Talia M Nir; Xue Hua; Boris A Gutman; Aram Galstyan; Paul M Thompson Journal: Proc IEEE Int Symp Biomed Imaging Date: 2015-04
Authors: Andrea R Zammit; Mindy J Katz; Jennifer Y Lai; Molly E Zimmerman; Markus Bitzer; Richard B Lipton Journal: J Gerontol A Biol Sci Med Sci Date: 2014-11-13 Impact factor: 6.053
Authors: Aaron J Carman; Rennie Ferguson; Robert Cantu; R Dawn Comstock; Penny A Dacks; Steven T DeKosky; Sam Gandy; James Gilbert; Chad Gilliland; Gerard Gioia; Christopher Giza; Michael Greicius; Brian Hainline; Ronald L Hayes; James Hendrix; Barry Jordan; James Kovach; Rachel F Lane; Rebekah Mannix; Thomas Murray; Tad Seifert; Diana W Shineman; Eric Warren; Elisabeth Wilde; Huntington Willard; Howard M Fillit Journal: Nat Rev Neurol Date: 2015-03-17 Impact factor: 42.937
Authors: Jing Dong; Annah Wyss; Jingyun Yang; T Ryan Price; Aude Nicolas; Michael Nalls; Greg Tranah; Nora Franceschini; Zongli Xu; Claudia Schulte; Alvaro Alonso; Steven R Cummings; Myriam Fornage; Dmitri Zaykin; Leping Li; Xuemei Huang; Stephen Kritchevsky; Yongmei Liu; Thomas Gasser; Robert S Wilson; Philip L De Jager; Andrew B Singleton; Jayant M Pinto; Tamara Harris; Thomas H Mosley; David A Bennett; Stephanie London; Lei Yu; Honglei Chen Journal: Mol Neurobiol Date: 2016-11-23 Impact factor: 5.590